Amil Shah is a Cardiology physician affiliated with Harold C. Simmons Comprehensive Cancer Center. OpenAlex indexes 700 publications with 24,778 citations (h-index 79); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
5200 Harry Hines Blvd
Dallas, TX 752357709
Telephone
214-590-8000Provider last certified this registry record 4 Aug 2023.
Clinical trials
- The Return of Cardiovascular Information Trial (RECITE)
Sponsor: University of Texas Southwestern Medical Center
- Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer
Sponsor: YM BioSciences
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Actelion Pharmaceuticals, LtdProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.3%Statin27.6%Atorvastatin Calcium56%Rosuvastatin Calcium44%Part D<11 patientsBeta blocker25.6%Metoprolol Succinate100%Part D≥15 patients+ 3 more classes in this area
Blood & clotting
23.7%Factor Xa inhibitor23.7%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
7 NIH research awards on record, funded 2021–2026 per NIH RePORTER. The latest:
- Late-life trajectories of cardiac function to define pathways of cardiac resilience
Ut Southwestern Medical Center
FY2026$1,773,275R01HL135008 - Proteomic profiling to identify mechanisms of susceptibility and resilience to cardiac dysfunction in Black Americans
Ut Southwestern Medical Center
FY2026$689,164R01HL172495 - Late-life trajectories of cardiac function to define pathways of cardiac resilience
Ut Southwestern Medical Center
FY2025$1,924,088R01HL135008
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Herbert Zeh, MD
Harold C. Simmons Comprehensive Cancer Center
John Minna, MD
Harold C. Simmons Comprehensive Cancer Center
Carlos Arteaga, MD
Harold C. Simmons Comprehensive Cancer Center
Hans Hammers, MD, PhD
Harold C. Simmons Comprehensive Cancer Center
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”